Evidence map›Paper›PMID 38249129›Full record

ArticleBiomicrofluidics2024

A microfluidic cover converts a standard 96-well plate into a mass-transport-controlled immunoassay system.

Sheng Wang, You Zhou, Zhenyu Li

Abstract read
In one paragraph

Article in Biomicrofluidics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sheng WangDepartment of Biomedical Engineering, The George Washington University, District of Columbia, 20052, USA.ORCID https://orcid.org/0000-0002-2051-4426
You ZhouDepartment of Electrical and Computer Engineering, The George Washington University, District of Columbia, 20052, USA.ORCID https://orcid.org/0000-0001-5999-5696
Zhenyu LiDepartment of Biomedical Engineering, The George Washington University, District of Columbia, 20052, USA.ORCID https://orcid.org/0000-0002-7752-6225

Funding

Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenationR01HL144157 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI ENTCHEVA, EMILIA, KAY, MATTHEW W. · 2019 to 2022
$2.8M
Ambulatory Sensor Arrays for Real-Life Monitoring of Pediatric Patients with AsthmaU01EB021986 · NIBIB · GEORGE WASHINGTON UNIVERSITY · PI LI, ZHENYU · 2015 to 2015
$2.0M
NHLBI NIH HHS R01 HL144157NIBIB NIH HHS U01 EB021986
6 · The paper itself

Abstract

96-well microtiter plates, widely used in immunoassays, face challenges such as prolonged assay time and limited sensitivity due to the lack of analyte transport control. Orbital shakers, commonly employed to facilitate mass transport, offer limited improvements and can introduce assay inconsistencies. While microfluidic devices offer performance enhancements, their complexity and incompatibility with existing platforms limit their wide adoption. This study introduces a novel microfluidic 96-well cover designed to convert a standard 96-well plate to a mass-transport-controlled surface bioreactor. The cover employs microfluidic methods to enhance the diffusion flux of analytes toward the receptors immobilized on the well bottom. Both simulation and experimental results demonstrated that the cover significantly enhances the capture rate of analyte molecules, resulting in increased signal strength for various detection methods and a lower detection limit. The cover serves as an effective add-on to standard 96-well plates, offering enhanced assay performance without requiring modifications to existing infrastructure or reagents. This innovation holds promise for improving the efficiency and reliability of microtiter plate based immunoassays.

Identifiers

PMID38249129
PMCPMC10798817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.